WO2023221015A1 - Cosmetic emulsion with reduced white appearance on skin - Google Patents
Cosmetic emulsion with reduced white appearance on skin Download PDFInfo
- Publication number
- WO2023221015A1 WO2023221015A1 PCT/CN2022/093730 CN2022093730W WO2023221015A1 WO 2023221015 A1 WO2023221015 A1 WO 2023221015A1 CN 2022093730 W CN2022093730 W CN 2022093730W WO 2023221015 A1 WO2023221015 A1 WO 2023221015A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- weight
- silica
- emulsion
- silylate
- preferred
- Prior art date
Links
- 239000008271 cosmetic emulsion Substances 0.000 title claims abstract description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical class O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 53
- 239000002245 particle Substances 0.000 claims abstract description 19
- VWJZZXVHKZPGLL-UHFFFAOYSA-N 3-methyldecane-1,2,3-triol Chemical compound CCCCCCCC(C)(C(CO)O)O VWJZZXVHKZPGLL-UHFFFAOYSA-N 0.000 claims abstract description 10
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 10
- 239000006260 foam Substances 0.000 claims abstract description 9
- 239000000839 emulsion Substances 0.000 claims description 46
- 239000000377 silicon dioxide Substances 0.000 claims description 30
- 239000000203 mixture Substances 0.000 claims description 15
- 229920002545 silicone oil Polymers 0.000 claims description 7
- 229940008099 dimethicone Drugs 0.000 claims description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 6
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 6
- 239000003921 oil Substances 0.000 description 23
- 235000019198 oils Nutrition 0.000 description 23
- 229940060184 oil ingredients Drugs 0.000 description 17
- 125000004432 carbon atom Chemical group C* 0.000 description 12
- 150000002191 fatty alcohols Chemical class 0.000 description 11
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 11
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 229920006395 saturated elastomer Polymers 0.000 description 9
- 239000003995 emulsifying agent Substances 0.000 description 8
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 8
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 8
- 150000002148 esters Chemical class 0.000 description 7
- 239000000230 xanthan gum Substances 0.000 description 6
- 229920001285 xanthan gum Polymers 0.000 description 6
- 235000010493 xanthan gum Nutrition 0.000 description 6
- 229940082509 xanthan gum Drugs 0.000 description 6
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 5
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 5
- 230000003254 anti-foaming effect Effects 0.000 description 5
- 239000002518 antifoaming agent Substances 0.000 description 5
- 229940100524 ethylhexylglycerin Drugs 0.000 description 5
- 229940049294 glyceryl stearate se Drugs 0.000 description 5
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 5
- 239000012875 nonionic emulsifier Substances 0.000 description 5
- 229960005323 phenoxyethanol Drugs 0.000 description 5
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 4
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 4
- 229920002148 Gellan gum Polymers 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- HPEUJPJOZXNMSJ-UHFFFAOYSA-N Methyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC HPEUJPJOZXNMSJ-UHFFFAOYSA-N 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- CKEVMZSLVHLLBF-UHFFFAOYSA-N benzyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CC=CC=C1 CKEVMZSLVHLLBF-UHFFFAOYSA-N 0.000 description 4
- GLYJVQDYLFAUFC-UHFFFAOYSA-N butyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCC GLYJVQDYLFAUFC-UHFFFAOYSA-N 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- XIRNKXNNONJFQO-UHFFFAOYSA-N ethyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC XIRNKXNNONJFQO-UHFFFAOYSA-N 0.000 description 4
- MMKRHZKQPFCLLS-UHFFFAOYSA-N ethyl myristate Chemical compound CCCCCCCCCCCCCC(=O)OCC MMKRHZKQPFCLLS-UHFFFAOYSA-N 0.000 description 4
- MVLVMROFTAUDAG-UHFFFAOYSA-N ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC MVLVMROFTAUDAG-UHFFFAOYSA-N 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000216 gellan gum Substances 0.000 description 4
- 235000010492 gellan gum Nutrition 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 229940100554 isononyl isononanoate Drugs 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- BEKZXQKGTDVSKX-UHFFFAOYSA-N propyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCC BEKZXQKGTDVSKX-UHFFFAOYSA-N 0.000 description 4
- BTAXGNQLYFDKEF-UHFFFAOYSA-N propyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCC BTAXGNQLYFDKEF-UHFFFAOYSA-N 0.000 description 4
- 150000004671 saturated fatty acids Chemical class 0.000 description 4
- 235000003441 saturated fatty acids Nutrition 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 4
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 4
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 4
- DDPKRUJMDMNPFK-GGNKOBOLSA-N (z)-4-[(z)-18-[2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propoxy]-18-oxooctadec-9-en-7-yl]oxy-4-oxobut-2-enoic acid Chemical compound CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(CCCCCC)OC(=O)\C=C/C(O)=O DDPKRUJMDMNPFK-GGNKOBOLSA-N 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- -1 2-ethylhexyl Chemical group 0.000 description 3
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 3
- 241001135917 Vitellaria paradoxa Species 0.000 description 3
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 229940075529 glyceryl stearate Drugs 0.000 description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 2
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 2
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 2
- KWVPFECTOKLOBL-KTKRTIGZSA-N 2-[(z)-octadec-9-enoxy]ethanol Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCO KWVPFECTOKLOBL-KTKRTIGZSA-N 0.000 description 2
- LWLRMRFJCCMNML-UHFFFAOYSA-N 2-ethylhexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(CC)CCCC LWLRMRFJCCMNML-UHFFFAOYSA-N 0.000 description 2
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 2
- OPJWPPVYCOPDCM-UHFFFAOYSA-N 2-ethylhexyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC OPJWPPVYCOPDCM-UHFFFAOYSA-N 0.000 description 2
- IKVCSHRLYCDSFD-UHFFFAOYSA-N 2-hexadecanoyloxyethyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCC IKVCSHRLYCDSFD-UHFFFAOYSA-N 0.000 description 2
- KMUBFTBPGVULKC-UHFFFAOYSA-N 2-hexyldecyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC KMUBFTBPGVULKC-UHFFFAOYSA-N 0.000 description 2
- MWKPHOIHTLQZIY-UHFFFAOYSA-N 2-hexyldecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC MWKPHOIHTLQZIY-UHFFFAOYSA-N 0.000 description 2
- NKEQOUMMGPBKMM-UHFFFAOYSA-N 2-hydroxy-2-[2-(2-hydroxy-3-octadecanoyloxypropoxy)-2-oxoethyl]butanedioic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CC(O)(C(O)=O)CC(O)=O NKEQOUMMGPBKMM-UHFFFAOYSA-N 0.000 description 2
- RUDXBXPTJPNTSO-UHFFFAOYSA-N 2-octyldodecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC RUDXBXPTJPNTSO-UHFFFAOYSA-N 0.000 description 2
- SJIDAAGFCNIAJP-UHFFFAOYSA-N 6-methylheptyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCC(C)C SJIDAAGFCNIAJP-UHFFFAOYSA-N 0.000 description 2
- XUVVLJKRLAXOKZ-UHFFFAOYSA-N 7-methyloctyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCC(C)C XUVVLJKRLAXOKZ-UHFFFAOYSA-N 0.000 description 2
- KGKQNDQDVZQTAG-UHFFFAOYSA-N 8-methylnonyl 2,2-dimethylpropanoate Chemical compound CC(C)CCCCCCCOC(=O)C(C)(C)C KGKQNDQDVZQTAG-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 229910002012 Aerosil® Inorganic materials 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 2
- VQENOYXMFIFHCY-UHFFFAOYSA-N Monoglyceride citrate Chemical compound OCC(O)COC(=O)CC(O)(C(O)=O)CC(O)=O VQENOYXMFIFHCY-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- NKSOSPOXQKNIKJ-CLFAGFIQSA-N Polyoxyethylene dioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCOC(=O)CCCCCCC\C=C/CCCCCCCC NKSOSPOXQKNIKJ-CLFAGFIQSA-N 0.000 description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
- BZUVPTAFNJMPEZ-CLFAGFIQSA-N [(z)-docos-13-enyl] (z)-docos-13-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCOC(=O)CCCCCCCCCCC\C=C/CCCCCCCC BZUVPTAFNJMPEZ-CLFAGFIQSA-N 0.000 description 2
- TXZRBCSUYLEATA-GALHSAGASA-N [(z)-docos-13-enyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC TXZRBCSUYLEATA-GALHSAGASA-N 0.000 description 2
- SZAMSYKZCSDVBH-CLFAGFIQSA-N [(z)-octadec-9-enyl] (z)-docos-13-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(=O)OCCCCCCCC\C=C/CCCCCCCC SZAMSYKZCSDVBH-CLFAGFIQSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000012874 anionic emulsifier Substances 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- BPSLVNCMKDXZPC-UHFFFAOYSA-N benzyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC1=CC=CC=C1 BPSLVNCMKDXZPC-UHFFFAOYSA-N 0.000 description 2
- BTBAANGSAVTDSG-UHFFFAOYSA-N butan-2-yl octanoate;2-butyloctanoic acid Chemical compound CCCCCCCC(=O)OC(C)CC.CCCCCCC(C(O)=O)CCCC BTBAANGSAVTDSG-UHFFFAOYSA-N 0.000 description 2
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- ULBTUVJTXULMLP-UHFFFAOYSA-N butyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCC ULBTUVJTXULMLP-UHFFFAOYSA-N 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 229940081733 cetearyl alcohol Drugs 0.000 description 2
- 229940071160 cocoate Drugs 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000007334 copolymerization reaction Methods 0.000 description 2
- 239000008406 cosmetic ingredient Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 2
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- CAMHHLOGFDZBBG-UHFFFAOYSA-N epoxidized methyl oleate Natural products CCCCCCCCC1OC1CCCCCCCC(=O)OC CAMHHLOGFDZBBG-UHFFFAOYSA-N 0.000 description 2
- 229940067592 ethyl palmitate Drugs 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- PMMXXYHTOMKOAZ-UHFFFAOYSA-N hexadecyl 7-methyloctanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCC(C)C PMMXXYHTOMKOAZ-UHFFFAOYSA-N 0.000 description 2
- RAMRROOXFMYSNA-UHFFFAOYSA-N hexadecyl benzoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C1=CC=CC=C1 RAMRROOXFMYSNA-UHFFFAOYSA-N 0.000 description 2
- 229940090854 hexyldecyl laurate Drugs 0.000 description 2
- 230000005661 hydrophobic surface Effects 0.000 description 2
- 229940078545 isocetyl stearate Drugs 0.000 description 2
- 229940093629 isopropyl isostearate Drugs 0.000 description 2
- 229940074928 isopropyl myristate Drugs 0.000 description 2
- 229940075495 isopropyl palmitate Drugs 0.000 description 2
- 229940089456 isopropyl stearate Drugs 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229940043348 myristyl alcohol Drugs 0.000 description 2
- KPWVFNOPNOTYNJ-UHFFFAOYSA-N octadecyl benzoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)C1=CC=CC=C1 KPWVFNOPNOTYNJ-UHFFFAOYSA-N 0.000 description 2
- QAOJADINKLMTRR-UHFFFAOYSA-N octan-3-yl 16-methylheptadecanoate Chemical compound CCCCCC(CC)OC(=O)CCCCCCCCCCCCCCC(C)C QAOJADINKLMTRR-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 2
- 229940095127 oleth-20 Drugs 0.000 description 2
- 229940120511 oleyl erucate Drugs 0.000 description 2
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 2
- LSTDYDRCKUBPDI-UHFFFAOYSA-N palmityl acetate Chemical compound CCCCCCCCCCCCCCCCOC(C)=O LSTDYDRCKUBPDI-UHFFFAOYSA-N 0.000 description 2
- PZQSQRCNMZGWFT-QXMHVHEDSA-N propan-2-yl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC(C)C PZQSQRCNMZGWFT-QXMHVHEDSA-N 0.000 description 2
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 2
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 2
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 2
- PVNIQBQSYATKKL-UHFFFAOYSA-N tripalmitin Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- ZQCIPRGNRQXXSK-UHFFFAOYSA-N 1-octadecoxypropan-2-ol Chemical compound CCCCCCCCCCCCCCCCCCOCC(C)O ZQCIPRGNRQXXSK-UHFFFAOYSA-N 0.000 description 1
- HANWHVWXFQSQGJ-UHFFFAOYSA-N 1-tetradecoxytetradecane Chemical compound CCCCCCCCCCCCCCOCCCCCCCCCCCCCC HANWHVWXFQSQGJ-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- 229920000536 2-Acrylamido-2-methylpropane sulfonic acid Polymers 0.000 description 1
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-ethylhexan-1-ol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- XXBAQTDVRLRXEV-UHFFFAOYSA-N 3-tetradecoxypropan-1-ol Chemical compound CCCCCCCCCCCCCCOCCCO XXBAQTDVRLRXEV-UHFFFAOYSA-N 0.000 description 1
- JFMGYULNQJPJCY-UHFFFAOYSA-N 4-(hydroxymethyl)-1,3-dioxolan-2-one Chemical compound OCC1COC(=O)O1 JFMGYULNQJPJCY-UHFFFAOYSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241000454552 Astrocaryum murumuru Species 0.000 description 1
- 235000000016 Astrocaryum murumuru Nutrition 0.000 description 1
- 235000004804 Astrocaryum sp Nutrition 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 235000008474 Cardamine pratensis Nutrition 0.000 description 1
- 240000000606 Cardamine pratensis Species 0.000 description 1
- 235000015214 Cardamine pratensis var. angustifolia Nutrition 0.000 description 1
- 235000015213 Cardamine pratensis var. pratensis Nutrition 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 238000007869 Guerbet synthesis reaction Methods 0.000 description 1
- 235000019487 Hazelnut oil Nutrition 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 241000218378 Magnolia Species 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 244000183331 Nephelium lappaceum Species 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 235000019498 Walnut oil Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 239000010478 argan oil Substances 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940098781 c18-36 acid triglyceride Drugs 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000000828 canola oil Substances 0.000 description 1
- 235000019519 canola oil Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 229940100836 castoryl maleate Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- INSRQEMEVAMETL-UHFFFAOYSA-N decane-1,1-diol Chemical compound CCCCCCCCCC(O)O INSRQEMEVAMETL-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 239000010468 hazelnut oil Substances 0.000 description 1
- GCXZDAKFJKCPGK-UHFFFAOYSA-N heptane-1,2-diol Chemical compound CCCCCC(O)CO GCXZDAKFJKCPGK-UHFFFAOYSA-N 0.000 description 1
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000002649 leather substitute Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 125000005395 methacrylic acid group Chemical group 0.000 description 1
- 229940100573 methylpropanediol Drugs 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 229940115458 pantolactone Drugs 0.000 description 1
- SIEVQTNTRMBCHO-UHFFFAOYSA-N pantolactone Natural products CC1(C)OC(=O)CC1O SIEVQTNTRMBCHO-UHFFFAOYSA-N 0.000 description 1
- SERHXTVXHNVDKA-UHFFFAOYSA-N pantolactone Chemical compound CC1(C)COC(=O)C1O SERHXTVXHNVDKA-UHFFFAOYSA-N 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229940078491 ppg-15 stearyl ether Drugs 0.000 description 1
- 229940116987 ppg-3 myristyl ether Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000001944 prunus armeniaca kernel oil Substances 0.000 description 1
- 239000008171 pumpkin seed oil Substances 0.000 description 1
- 235000007861 rambutan Nutrition 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- YRWWOAFMPXPHEJ-OFBPEYICSA-K sodium L-ascorbic acid 2-phosphate Chemical compound [Na+].[Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1[O-] YRWWOAFMPXPHEJ-OFBPEYICSA-K 0.000 description 1
- 229940048058 sodium ascorbyl phosphate Drugs 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 239000010496 thistle oil Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000008170 walnut oil Substances 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
- A61K2800/34—Free of silicones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/61—Surface treated
- A61K2800/612—By organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/65—Characterized by the composition of the particulate/core
- A61K2800/651—The particulate/core comprising inorganic material
Definitions
- the present invention belongs to the cosmetic field and relates to a cosmetic emulsion which shows reduced white appearance after application.
- Cosmetic products generally not only serve to look beautiful and attractive, but their effects make a decisive contribution to increased self-esteem and people's wellbeing. Accordingly, a wide variety of cosmetic products are used for the daily cleaning and care of human skin.
- anti-foaming agents are included in body lotions and creams which reduce the time until the air bubbles and with it the white foam disappears. If no anti-foaming agents are used, the white appearance will need longer time to disappear, and the spreading/massage upon application to the skin will increase the foaming. Thus, for consumers, the skin care product will become whiter and whiter during applying, although finally it will disappear. As a result, the consumers will have the impression that the product is difficult to spread and absorb.
- the anti-foaming agents can help the air bubbles break and disappear faster, so the product seems to be easier spread and faster absorbed on skin.
- silicone oils are used as anti-foaming agent.
- E. g. dimethicone has low surface tension and is not easy to dissolve into water or other oil ingredients. As result it can easily move to the surface of the air bubbles and spread on the bubble surface. This process renders the surface of the bubble to become uneven so that the bubbles start to combine and break faster.
- Typical silicone oil based anti-foaming compositions are described in US5531929 A.
- EP 0339958 A3 describes encapsulated silicone anti-foaming compositions.
- Lexgard MG Natural MB is known under the INCI designation methylhepylglycerin. Datasheets suggest that it can be used as anti-foaming agent. However, the anti-foaming capabilities of this material are still limited.
- a first object of the present invention is a cosmetic emulsion comprising based on the total weight of the composition
- At least one hydrophobic or hydrophobically modified particle in particular hydrophobically modified silica
- the emulsions according to the invention allow the appearance of foaming after application to be reduced. It was particular surprising that a synergism was observed between the compounds.
- normal conditions refers to 20°C, 1013 hPa and a relative humidity of 50%.
- the term “free from” means that the proportion of the respective substance is less than 0.05%by weight. This ensures that entrainments or impurities with these substances are not included as “free from” according to the invention.
- hydrophobic particle is understood as a particle with a hydrophobic surface. These are particles which have a hydrophobic surface without being chemically modified.
- hydrophobically modified particle is understood as a particle which surface was hydrophobically modified.
- skin refers solely to the human skin.
- Silicone oils are known under the designation dimethicone and cyclomethicone.
- Emulsifiers are understood to be all substances which are listed in the International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition 2010, (ISBN 1-882621-47-6) under the name “emulsifying agent” .
- Surfactants are understood to be all substances which are listed in the International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition 2010, (ISBN 1-882621-47-6) under the name “surfactant” .
- the emulsion according to the invention comprises from 0.05 to 5%by weight of methylheptylglycerin. It is preferred if the total quantity of methylheptylglycerin is in the range from 0.1 to 2%by weight, more preferably from 0.2 to 1.5%by weight and most preferably from 0.3 to 1.1%by weight, calculated to the total weight of the emulsion.
- the emulsion comprises at least one hydrophobic or hydrophobically modified particle.
- the emulsion comprises at least preferably a hydrophobically modified silica. It is preferred according to the invention if the total quantity of hydrophobically modified silica is in the range 0.01 to 2.0%by weight, more preferably 0.02 to 1.0%and most preferably 0.03 to 0.25%by weight calculated to the total weight of the emulsion.
- Preferred hydrophobically modified silica is selected from the group consisting of silica silylate, silica cetyl silylate, silica caprylyl silylate; silica dimethicone silylate and silica dimethyl silylate. It is more preferred if silica cetyl silylate and/or silica caprylyl silylate are contained as hydrophobically modified silica.
- the total quantity of silica silylate, silica cetyl silylate, silica caprylyl silylate; silica dimethicone silylate and/or silica dimethyl silylate is in the range 0.01 to 2.0%by weight, more preferably 0.02 to 1.0%by weight and most preferably 0.03 to 0.25%by weight calculated to the total weight of the emulsion.
- the total quantity of silica cetyl silylate and/or silica caprylyl silylate is in the range 0.01 to 2.0%by weight, more preferably 0.02 to 1.0%by weight and most preferably 0.03 to 0.25%by weight calculated to the total weight of the emulsion.
- the hydrophobic or hydrophobically modified particles have a mean particle size of 17 to 300 ⁇ m, more preferably 20 to 100 ⁇ m and most preferably 30 to 80 ⁇ m.
- the hydrophobically modified silica has a mean particle size of 17 to 300 ⁇ m, more preferably 20 to 100 ⁇ m and most preferably 30 to 80 ⁇ m.
- the mean particle size is determined by laser scattering using a Horiba Laser Scattering Particle Size Distribution Analyzer LA-950.
- Hydrophobic silica sold under the trade name Aerosil R816 has a mean particle size of 54.5 ⁇ m.
- the emulsion comprises at least one oil chosen from the esters of the linear or branched saturated or unsaturated fatty alcohols having 2-30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2-30 carbon atoms, which may be hydroxylated
- the total quantity of esters of the linear or branched saturated or unsaturated fatty alcohols having 2-30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2-30 carbon atoms, which may be hydroxylated is in the range from 0.2 to 8.0%by weight, more preferably from 0.5 to 6.0 %by weight, more preferably 0.6 to 5.0%by weight and most preferably from 0.75 to 4.5%by weight, calculated to the total weight of the emulsion.
- Preferred esters of the linear or branched saturated or unsaturated fatty alcohols having 2-30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2-30 carbon atoms, which may be hydroxylated are selected from the group consisting of hexyldecyl stearate, hexyldecyl laurate, isodecyl neopentanoate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl stearate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl isostearate, isopropyl oleate, isooctyl stearate, isononyl stearate, isocetyl stearate, isononyl isononanoate, isotridecyl isononanoate, cetearyl
- isopropyl myristate and/or isopropyl palmitate are particular preferred.
- esters of the linear or branched saturated or unsaturated fatty alcohols having 2-30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2-30 carbon atoms which may be hydroxylated, selected from the group consisting of hexyldecyl stearate, hexyldecyl laurate, isodecyl neopentanoate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl stearate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl isostearate, isopropyl oleate, isooctyl stearate, isononyl stearate, isocetyl stearate, isononyl isononanoate, isotridecyl isonononon
- the total quantity of isopropyl myristate and/or isopropyl palmitate is in the range from 0.2 to 8.0%by weight, more preferably from 0.5 to 6.0 %by weight, more preferably 0.6 to 5.0%by weight and most preferably from 0.75 to 4.5%by weight, calculated to the total weight of the emulsion.
- At least one fatty acid triglyceride is contained in the emulsion.
- the total quantity of the fatty acid triglycerides is preferably in the range from 0.5 to 8.0%by weight, more preferably from 1.0 to 6.5%by weight, more preferably 2.1 to 6%by weight and most preferably from 2.2 to 5.0%by weight, calculated to the total weight of the emulsion.
- the fatty acid triglyceride is selected from Cocos Nucifera Oil (Triglyceride (Fractionated Coconut Oil) ) , Astrocaryum Murumuru Seed Butter (Astrocaryum sp Triglycerides) , C10-18 Triglycerides, C10-40 Isoalkyl Acid Triglyceride, C12-18 Acid Triglyceride, C18-36 Acid Triglyceride, C8-12 Acid Triglyceride, Caprylic/capric/myristic/stearic Triglyceride, Caprylic/Capric Triglyceride, Capric/Lauric/Myristic/Oleic Triglyceride, Caprylic/Capric/Linoleic Triglyceride, Caprylic/Capric/Stearic Triglyceride, Castoryl Maleate (Ceraphyl RMT (Ricinoleyl Monomaleate Triglyceride) ) , Hydrogenated C12-18 Triglycerides,
- Caprylic/Capric Triglyceride In particular preferred is Caprylic/Capric Triglyceride.
- the total quantity of the Caprylic/Capric Triglyceride is in the range from 0.5 to 8.0%by weight, more preferably from 1.0 to 6.5%by weight, more preferably 2.1 to 6%by weight and most preferably from 2.2 to 5.0%by weight, calculated to the total weight of the emulsion.
- the fatty acid triglyceride can also be part of natural oils.
- Preferred natural oils which can be contained are coconut oil, (sweet) almond oil, walnut oil, peach kernel oil, apricot kernel oil, avocado oil, tea tree oil, soybean oil, glycine soja oil, sesame oil, sunflower oil, tsubaki oil, evening primrose oil, rice bran oil, palm kernel oil, mango kernel oil, cuckoo flower oil, thistle oil, macadamia nut oil, grape seed oil, amaranth seed oil, argan oil, bamboo oil, olive oil, wheat germ oil, pumpkin seed oil, mallow oil, hazelnut oil, safflower oil, canola oil, sasanqua oil, jojoba oil, rambutan oil, cocoa butter, and shea butter.
- the emulsion comprises less than 0.1%or 0%by weight of polymers formed by homo-or copolymerization with acrylic acid and/or methacrylic.
- the emulsion comprises less than 0.1%or 0%by weight of polymers formed by homo-or copolymerization with 2-acrylamido-2-methylpropanesulfonic acid.
- the oil phase of the emulsion sums up to a total quantity in the range from 3.0 to 20.0%by weight, more preferably from 5.0 to 15%by weight and most preferably from 6.0 to 12.0%by weight, calculated to the total weight of the emulsion.
- emulsifier and surfactants are not part of the oil phase. Nevertheless, fatty alcohols count as part of the oil phase.
- Further compounds which can be contained in the oil phase are for example chosen from further branched saturated or unsaturated fatty alcohols having 6-30 carbon atoms. These alcohols are also often referred to as Guerbet alcohols since they are obtainable according to the Guerbet reaction.
- Preferred alcohol oils are hexyldecanol ( G 16, T 16) , octyldodecanol ( G, 20) and 2-ethylhexyl alcohol.
- oils preferred according to the invention are chosen from the addition products of from 1 to 5 propylene oxide units onto mono-or polyhydric C8-22-alkanols, such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, e.g., PPG-2 myristyl ether and PPG-3 myristyl ether ( APM) .
- mono-or polyhydric C8-22-alkanols such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, e.g., PPG-2 myristyl ether and PPG-3 myristyl ether ( APM) .
- oils which can be contained in the emulsion according to the invention are chosen from the addition products of at least 6 ethylene oxide and/or propylene oxide units onto mono-or polyhydric C3-22-alkanols, such as butanol, butanediol, myristyl alcohol and stearyl alcohol, e.g., PPG-14 butyl ether (Ucon AP) , PPG-9 butyl ether ( B25) , PPG-10 butanediol ( 57) and PPG-15 stearyl ether ( E) .
- PPG-14 butyl ether Ucon AP
- PPG-9 butyl ether B25
- PPG-10 butanediol 57
- PPG-15 stearyl ether E
- Further oils are preferably chosen from the C8-C22-fatty alcohol esters of monobasic or polybasic C2-C7-hydroxycarboxylic acids, in particular, the esters of glycolic acid, lactic acid, malic acid, tartaric acid, citric acid and salicylic acid.
- esters based on linear C14/15-alkanols, e.g., C12-C15-alkyl lactate, and on C12/13-alkanols branched in the 2 position are available under the trade name from Nordmann, Rassmann GmbH &Co., Hamburg, in particular the commercial products ESI, EMI and ETI.
- oils which can preferably be used are chosen from the symmetrical, asymmetrical or cyclic esters of carbonic acid with fatty alcohols, e.g., glycerol carbonate, dicaprylyl carbonate ( CC) or the esters of DE 197 56 454 A1.
- the emulsion comprises at least one fatty alcohol comprising 12 to 22 carbon atoms.
- fatty alcohols cetyl alcohol, stearyl alcohol, ceteary alcohol, and the corresponding mixture are most preferred.
- the total quantity of those fatty alcohols is in the range from 0.5 to 8.0%by weight, more preferably 1.5 to 6.0%by weight and most preferably 2.5 to 5.0 %by weight, calculated to the total weight of the emulsion.
- the emulsion comprises 0.05 to 1%by weight of at least one polymer selected from the group of xanthan gum, gellan gum, sclerotium gum and dehydroxanthan gum, calculated to the total weight of the composition. Those gums allow to build up a hydrogel structure in the formulation.
- At least xanthan gum is contained. Further it is particular preferred if at least gellan gum is contained. Further it is particular preferred if at least sclerotium gum is contained. Further it is particular preferred if at least dehydroxanthan gum is contained.
- the emulsion comprises 0.1 to 0.8%by weight, more preferably 0.12 to 0.5%by weight and most preferably 0.15 to 0.3%by weight of at least one polymer selected from the group of xanthan gum, gellan gum, sclerotium gum and dehydroxanthan gum, calculated to the total weight of the composition.
- xanthan gum Most preferred is the combination of xanthan gum and gellan gum.
- the emulsion according to the invention comprises further short chain polyols comprising 2 to 8 carbon atoms.
- those preferred polyols are contained in quantities ranging from 0.5 to 10%by weight, more preferably 1 to 9%by weight and most preferably from 1.5 to 8%by weight, calculated to the total weight of the composition.
- the emulsion comprises phenoxyethanol and/or ethylhexylglycerin.
- phenoxyethanol is contained it is preferred if the total quantity of phenoxyethanol is in the range from 0.1 to 2.0%by weight, preferably from 0.6 to 1.4%by weight, calculated to the total weight of the emulsion.
- ethylhexylglycerin is contained it is preferred if the total quantity of ethylhexylglycerin is in the range from 0.1 to 1.2%by weight, calculated to the total weight of the emulsion.
- nonionic emulsifier is contained.
- nonionic emulsifiers are selected from oleth-20, glyceryl stearate, glyceryl stearate SE and PEG-40 hydrogenated castor oil.
- glyceryl stearate and/or glyceryl stearate SE are particularly preferred.
- the total quantity of the nonionic emulsifier is in the range from 0.2 to 4.0%by weight, more preferably from 0.5 to 3.0%by weight and most preferably 1.3 to 2.8%by weight, calculated to the total weight of the emulsion.
- nonionic emulsifier selected from oleth-20, glyceryl stearate, glyceryl stearate SE and PEG-40 hydrogenated castor oil
- the total quantity of those nonionic emulsifier is in the range from 0.2 to 4.0%by weight, more preferably from 0.5 to 3.0%by weight and most preferably 1.3 to 2.8%by weight, calculated to the total weight of the emulsion.
- At least one anionic emulsifier is contained, which is advantageously selected from the group of anionic emulsifiers having a hlb value ranging from 8 to 18, in particular from 10 to 15.
- Preferred anionic emulsifiers are selected from glyceryl stearate citrate, sodium cetearyl sulfate and glyceryl citrate.
- the total quantity of anionic emulsifier is in the range from 0.05 to 2.0%by weight, more preferably 0.07 to 0.3%by weight, calculated to the total weight of the emulsion.
- the total quantity of glyceryl stearate citrate, sodium cetearyl sulfate and/or glyceryl citrate is in the range from 0.05 to 2.0%by weight, more preferably 0.07 to 0.3%by weight, calculated to the total weight of the emulsion.
- active ingredients are contained. These are advantageously selected from the group containing sodium hyaluronate, 1-methylhydantoin-2-imide, creatine, folic acid, panthenol, pantolactone, vitamin C, magnolia, calcium pantothenate and sodium ascorbyl phosphate.
- the active ingredients mentioned in the group are advantageously used in total proportions of up to 2%by weight, preferably less than 1%by weight, based on the total weight of the composition.
- the emulsion is an oil in water emulsion.
- water is contained in the emulsion in a total quantity ranging from 75.0%by weight to 95.0%by weight, calculated to the total weight of the emulsion.
- Figure 1 shows a picture of Example 1
- Figure 2 shows a picture of Example 2
- Figure 3 shows a picture of Example 3.
- Figure 4 shows a picture of Example 4.
- test sample test sample
- Pipette which can measure 200 ⁇ L sample
- artificial skin black PU artificial leather
- metronome stopwatch
- camera photograph light box
- camera fixing system
- imageJ image analyze software
- Example 1 is a reference example containing methylheptylglycerin. Adding a hydrophobic particle, here silica cetyl silylate, allows a significant reduction of appearance of white foam, indicating a synergism (Ex. 2, Figure 2) . If only silica cetyl silylate is contained (Ex. 4) almost no reduction is observed (Figure 4) .
- a hydrophobic particle here silica cetyl silylate
Abstract
A cosmetic emulsion comprises methylheptylglycerin and at least one hydrophobic or hydrophobically modified particle, in particular hydrophobically modified silica, for reducing white foam after application.
Description
The present invention belongs to the cosmetic field and relates to a cosmetic emulsion which shows reduced white appearance after application.
Background art
Cosmetic products generally not only serve to look beautiful and attractive, but their effects make a decisive contribution to increased self-esteem and people's wellbeing. Accordingly, a wide variety of cosmetic products are used for the daily cleaning and care of human skin.
When applying cosmetic products such as body lotions and creams which contain an oil and an aqueous phase it is often observed that small air bubbles of the composition are formed on the skin. These air bubbles can be described as foam which has a white appearance. Typically, this foam disappears in a couple of minutes after application to the skin.
In most cases anti-foaming agents are included in body lotions and creams which reduce the time until the air bubbles and with it the white foam disappears. If no anti-foaming agents are used, the white appearance will need longer time to disappear, and the spreading/massage upon application to the skin will increase the foaming. Thus, for consumers, the skin care product will become whiter and whiter during applying, although finally it will disappear. As a result, the consumers will have the impression that the product is difficult to spread and absorb. The anti-foaming agents can help the air bubbles break and disappear faster, so the product seems to be easier spread and faster absorbed on skin.
Most often silicone oils are used as anti-foaming agent. E. g. dimethicone has low surface tension and is not easy to dissolve into water or other oil ingredients. As result it can easily move to the surface of the air bubbles and spread on the bubble surface. This process renders the surface of the bubble to become uneven so that the bubbles start to combine and break faster.
Typical silicone oil based anti-foaming compositions are described in US5531929 A. EP 0339958 A3 describes encapsulated silicone anti-foaming compositions.
However, the use of silicone oils has been controversially discussed for various reasons in recent years. Thus, consumers generally prefer products which do not require the presence of silicone oils. Nevertheless, the appearance of foam upon applications shall remain at a limited level. That means the amount of foam and the time upon disappearance of the white foam shall be reduced.
Lexgard MG Natural MB is known under the INCI designation methylhepylglycerin. Datasheets suggest that it can be used as anti-foaming agent. However, the anti-foaming capabilities of this material are still limited.
Summary of the invention
It was surprisingly found by the application that the antifoaming capabilities can be improved by the present invention.
A first object of the present invention is a cosmetic emulsion comprising based on the total weight of the composition
a. 0.05 to 5.0%by weight of methylheptylglycerin,
b. At least one hydrophobic or hydrophobically modified particle, in particular hydrophobically modified silica,
c. less than 0.1%or 0%by weight of a silicone oil.
It was surprisingly noticed that the emulsions according to the invention allow the appearance of foaming after application to be reduced. It was particular surprising that a synergism was observed between the compounds.
All the weight percentages (%by weight) given below relate, unless otherwise stated, to the total weight of the cosmetic emulsion. If ratios of certain components are disclosed in the following description, these ratios refer, unless otherwise stated, to weight ratios of the components.
Unless otherwise stated, all tests and measurements were performed under “normal conditions” . The term "normal conditions" refers to 20℃, 1013 hPa and a relative humidity of 50%.
In the following description the terms ” according to the invention” , “preferred according to the invention” and so on are always directed to the use according to the invention, to the composition and to the method according to the invention.
For the purposes of the present disclosure, the term "free from" means that the proportion of the respective substance is less than 0.05%by weight. This ensures that entrainments or impurities with these substances are not included as "free from" according to the invention.
The term “hydrophobic particle” is understood as a particle with a hydrophobic surface. These are particles which have a hydrophobic surface without being chemically modified.
The term “hydrophobically modified particle” is understood as a particle which surface was hydrophobically modified.
The term “skin” refers solely to the human skin.
Silicone oils are known under the designation dimethicone and cyclomethicone.
Emulsifiers are understood to be all substances which are listed in the International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition 2010, (ISBN 1-882621-47-6) under the name "emulsifying agent" . Surfactants are understood to be all substances which are listed in the International Cosmetic Ingredient Dictionary and Handbook, Thirteenth Edition 2010, (ISBN 1-882621-47-6) under the name "surfactant" .
The emulsion according to the invention comprises from 0.05 to 5%by weight of methylheptylglycerin. It is preferred if the total quantity of methylheptylglycerin is in the range from 0.1 to 2%by weight, more preferably from 0.2 to 1.5%by weight and most preferably from 0.3 to 1.1%by weight, calculated to the total weight of the emulsion.
According to the invention the emulsion comprises at least one hydrophobic or hydrophobically modified particle. According to the invention the emulsion comprises at least preferably a hydrophobically modified silica. It is preferred according to the invention if the total quantity of hydrophobically modified silica is in the range 0.01 to 2.0%by weight, more preferably 0.02 to 1.0%and most preferably 0.03 to 0.25%by weight calculated to the total weight of the emulsion.
Preferred hydrophobically modified silica is selected from the group consisting of silica silylate, silica cetyl silylate, silica caprylyl silylate; silica dimethicone silylate and silica dimethyl silylate. It is more preferred if silica cetyl silylate and/or silica caprylyl silylate are contained as hydrophobically modified silica.
Accordingly, it is preferred the total quantity of silica silylate, silica cetyl silylate, silica caprylyl silylate; silica dimethicone silylate and/or silica dimethyl silylate is in the range 0.01 to 2.0%by weight, more preferably 0.02 to 1.0%by weight and most preferably 0.03 to 0.25%by weight calculated to the total weight of the emulsion.
Further it is preferred if the total quantity of silica cetyl silylate and/or silica caprylyl silylate is in the range 0.01 to 2.0%by weight, more preferably 0.02 to 1.0%by weight and most preferably 0.03 to 0.25%by weight calculated to the total weight of the emulsion.
According to the invention it is preferred if the hydrophobic or hydrophobically modified particles have a mean particle size of 17 to 300 μm, more preferably 20 to 100 μm and most preferably 30 to 80 μm. According to the invention it is preferred if the hydrophobically modified silica has a mean particle size of 17 to 300 μm, more preferably 20 to 100 μm and most preferably 30 to 80 μm. The mean particle size is determined by laser scattering using a Horiba Laser Scattering Particle Size Distribution Analyzer LA-950. Hydrophobic silica sold under the trade name Aerosil R816 has a mean particle size of 54.5 μm.
According to the invention it is preferred if the emulsion comprises at least one oil chosen from the esters of the linear or branched saturated or unsaturated fatty alcohols having 2-30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2-30 carbon atoms, which may be hydroxylated
According to the invention, it is preferred if the total quantity of esters of the linear or branched saturated or unsaturated fatty alcohols having 2-30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2-30 carbon atoms, which may be hydroxylated, is in the range from 0.2 to 8.0%by weight, more preferably from 0.5 to 6.0 %by weight, more preferably 0.6 to 5.0%by weight and most preferably from 0.75 to 4.5%by weight, calculated to the total weight of the emulsion.
Preferred esters of the linear or branched saturated or unsaturated fatty alcohols having 2-30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2-30 carbon atoms, which may be hydroxylated, are selected from the group consisting of hexyldecyl stearate, hexyldecyl laurate, isodecyl neopentanoate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl stearate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl isostearate, isopropyl oleate, isooctyl stearate, isononyl stearate, isocetyl stearate, isononyl isononanoate, isotridecyl isononanoate, cetearyl isononanoate, 2-ethylhexyl laurate, 2-ethylhexyl isostearate, 2-ethylhexyl cocoate, 2-octyldodecyl palmitate, butyloctanoic acid-2-butyl octanoate, diisotridecyl acetate, ethyl stearate, methyl stearate, , propyl stearate, butyl stearate, ethyl myristate, ethyl palmitate, butyl palmitate, propyl stearate, propyl palmitate, stearyl benzoate, benzyl palmitate, benzyl stearate, palmityl benzoate, C12-15 alkyl benzoate, palmityl acetate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate, ethylene glycol dioleate and ethylene glycol dipalmitate.
Among those isopropyl myristate and/or isopropyl palmitate are particular preferred.
Accordingly it is preferred if the total quantity of esters of the linear or branched saturated or unsaturated fatty alcohols having 2-30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2-30 carbon atoms, which may be hydroxylated, selected from the group consisting of hexyldecyl stearate, hexyldecyl laurate, isodecyl neopentanoate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl stearate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl isostearate, isopropyl oleate, isooctyl stearate, isononyl stearate, isocetyl stearate, isononyl isononanoate, isotridecyl isononanoate, cetearyl isononanoate, 2-ethylhexyl laurate, 2-ethylhexyl isostearate, 2-ethylhexyl cocoate, 2-octyldodecyl palmitate, butyloctanoic acid-2-butyl octanoate, diisotridecyl acetate, ethyl stearate, methyl stearate, propyl stearate, butyl stearate, ethyl myristate, ethyl palmitate, butyl palmitate, propyl stearate, propyl palmitate, stearyl benzoate, benzyl palmitate, benzyl stearate, palmityl benzoate, C12-15 alkyl benzoate, palmityl acetate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate, ethylene glycol dioleate and ethylene glycol dipalmitate is in the range from 0.2 to 8.0%by weight, more preferably from 0.5 to 6.0 %by weight, more preferably 0.6 to 5.0%by weight and most preferably from 0.75 to 4.5%by weight, calculated to the total weight of the emulsion.
Further it is preferred if the total quantity of isopropyl myristate and/or isopropyl palmitate is in the range from 0.2 to 8.0%by weight, more preferably from 0.5 to 6.0 %by weight, more preferably 0.6 to 5.0%by weight and most preferably from 0.75 to 4.5%by weight, calculated to the total weight of the emulsion.
Further it is preferred if at least one fatty acid triglyceride is contained in the emulsion. The total quantity of the fatty acid triglycerides is preferably in the range from 0.5 to 8.0%by weight, more preferably from 1.0 to 6.5%by weight, more preferably 2.1 to 6%by weight and most preferably from 2.2 to 5.0%by weight, calculated to the total weight of the emulsion.
It is preferred if the fatty acid triglyceride is selected from Cocos Nucifera Oil (Triglyceride (Fractionated Coconut Oil) ) , Astrocaryum Murumuru Seed Butter (Astrocaryum sp Triglycerides) , C10-18 Triglycerides, C10-40 Isoalkyl Acid Triglyceride, C12-18 Acid Triglyceride, C18-36 Acid Triglyceride, C8-12 Acid Triglyceride, Caprylic/capric/myristic/stearic Triglyceride, Caprylic/Capric Triglyceride, Capric/Lauric/Myristic/Oleic Triglyceride, Caprylic/Capric/Linoleic Triglyceride, Caprylic/Capric/Stearic Triglyceride, Castoryl Maleate (Ceraphyl RMT (Ricinoleyl Monomaleate Triglyceride) ) , Hydrogenated C12-18 Triglycerides, Lauric/palmitic/oleic Triglyceride, Mustelic/palmitic Triglyceride, Oleic/linoleic Triglyceride, Oleic/Palmitic/Lauric/Myristic/Linoleic Triglyceride, Ricinoleic/caproic/caprylic/capric Triglyceride, Caprylic/Capric/Succinic Triglyceride and/or Jojoba Oil/Caprylic/Capric Triglyceride Esters.
In particular preferred is Caprylic/Capric Triglyceride. Thus, it is particular preferred if the total quantity of the Caprylic/Capric Triglyceride is in the range from 0.5 to 8.0%by weight, more preferably from 1.0 to 6.5%by weight, more preferably 2.1 to 6%by weight and most preferably from 2.2 to 5.0%by weight, calculated to the total weight of the emulsion.
The fatty acid triglyceride can also be part of natural oils. Preferred natural oils, which can be contained are coconut oil, (sweet) almond oil, walnut oil, peach kernel oil, apricot kernel oil, avocado oil, tea tree oil, soybean oil, glycine soja oil, sesame oil, sunflower oil, tsubaki oil, evening primrose oil, rice bran oil, palm kernel oil, mango kernel oil, cuckoo flower oil, thistle oil, macadamia nut oil, grape seed oil, amaranth seed oil, argan oil, bamboo oil, olive oil, wheat germ oil, pumpkin seed oil, mallow oil, hazelnut oil, safflower oil, canola oil, sasanqua oil, jojoba oil, rambutan oil, cocoa butter, and shea butter.
According to the invention it is further preferred if the emulsion comprises less than 0.1%or 0%by weight of polymers formed by homo-or copolymerization with acrylic acid and/or methacrylic.
According to the invention it is further preferred if the emulsion comprises less than 0.1%or 0%by weight of polymers formed by homo-or copolymerization with 2-acrylamido-2-methylpropanesulfonic acid.
Further, it is preferred if the oil phase of the emulsion sums up to a total quantity in the range from 3.0 to 20.0%by weight, more preferably from 5.0 to 15%by weight and most preferably from 6.0 to 12.0%by weight, calculated to the total weight of the emulsion.
By definition emulsifier and surfactants are not part of the oil phase. Nevertheless, fatty alcohols count as part of the oil phase.
Further compounds which can be contained in the oil phase are for example chosen from further branched saturated or unsaturated fatty alcohols having 6-30 carbon atoms. These alcohols are also often referred to as Guerbet alcohols since they are obtainable according to the Guerbet reaction. Preferred alcohol oils are hexyldecanol (
G 16,
T 16) , octyldodecanol (
G,
20) and 2-ethylhexyl alcohol.
Further oils preferred according to the invention are chosen from the addition products of from 1 to 5 propylene oxide units onto mono-or polyhydric C8-22-alkanols, such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, e.g., PPG-2 myristyl ether and PPG-3 myristyl ether (
APM) .
Further oils, which can be contained in the emulsion according to the invention are chosen from the addition products of at least 6 ethylene oxide and/or propylene oxide units onto mono-or polyhydric C3-22-alkanols, such as butanol, butanediol, myristyl alcohol and stearyl alcohol, e.g., PPG-14 butyl ether (Ucon
AP) , PPG-9 butyl ether (
B25) , PPG-10 butanediol (
57) and PPG-15 stearyl ether (
E) .
Further oils are preferably chosen from the C8-C22-fatty alcohol esters of monobasic or polybasic C2-C7-hydroxycarboxylic acids, in particular, the esters of glycolic acid, lactic acid, malic acid, tartaric acid, citric acid and salicylic acid. Such esters based on linear C14/15-alkanols, e.g., C12-C15-alkyl lactate, and on C12/13-alkanols branched in the 2 position are available under the trade name
from Nordmann, Rassmann GmbH &Co., Hamburg, in particular the commercial products
ESI,
EMI and
ETI.
Further oils which can preferably be used are chosen from the symmetrical, asymmetrical or cyclic esters of carbonic acid with fatty alcohols, e.g., glycerol carbonate, dicaprylyl carbonate (
CC) or the esters of DE 197 56 454 A1.
Further, it is preferred if the emulsion comprises at least one fatty alcohol comprising 12 to 22 carbon atoms. Among those fatty alcohols cetyl alcohol, stearyl alcohol, ceteary alcohol, and the corresponding mixture are most preferred.
For the case at least one fatty alcohol comprising 12 to 22 carbon atoms is contained, it is preferred if the total quantity of those fatty alcohols is in the range from 0.5 to 8.0%by weight, more preferably 1.5 to 6.0%by weight and most preferably 2.5 to 5.0 %by weight, calculated to the total weight of the emulsion.
According to the invention the emulsion comprises 0.05 to 1%by weight of at least one polymer selected from the group of xanthan gum, gellan gum, sclerotium gum and dehydroxanthan gum, calculated to the total weight of the composition. Those gums allow to build up a hydrogel structure in the formulation.
It is particular preferred if at least xanthan gum is contained. Further it is particular preferred if at least gellan gum is contained. Further it is particular preferred if at least sclerotium gum is contained. Further it is particular preferred if at least dehydroxanthan gum is contained.
It is advantageous if the emulsion comprises 0.1 to 0.8%by weight, more preferably 0.12 to 0.5%by weight and most preferably 0.15 to 0.3%by weight of at least one polymer selected from the group of xanthan gum, gellan gum, sclerotium gum and dehydroxanthan gum, calculated to the total weight of the composition.
Most preferred is the combination of xanthan gum and gellan gum.
Further it is preferred if the emulsion according to the invention comprises further short chain polyols comprising 2 to 8 carbon atoms. Preferred polyols of that type are butylene glycol, glycerol (=glycerin) , propylene glycol, pentylene glycol, butylene glycol, 1, 2 hexanediol, 1, 2 heptanediol, 1, 2 propanediol, methylpropanediol and caprylyl glycol.
It is preferred if those preferred polyols are contained in quantities ranging from 0.5 to 10%by weight, more preferably 1 to 9%by weight and most preferably from 1.5 to 8%by weight, calculated to the total weight of the composition.
Further it is preferred if the emulsion comprises phenoxyethanol and/or ethylhexylglycerin.
For the case that phenoxyethanol is contained it is preferred if the total quantity of phenoxyethanol is in the range from 0.1 to 2.0%by weight, preferably from 0.6 to 1.4%by weight, calculated to the total weight of the emulsion.
For the case that ethylhexylglycerin is contained it is preferred if the total quantity of ethylhexylglycerin is in the range from 0.1 to 1.2%by weight, calculated to the total weight of the emulsion.
Further it is preferred according to the invention if at least one nonionic emulsifier is contained. Although, basically all nonionic emulsifiers can be contained in the emulsion of the invention, some emulsifiers were found to be particularly beneficial for the effect described. Preferred nonionic emulsifiers are selected from oleth-20, glyceryl stearate, glyceryl stearate SE and PEG-40 hydrogenated castor oil.
It is particularly preferred are glyceryl stearate and/or glyceryl stearate SE.
For the case that at least one nonionic emulsifier is contained, it is preferred if the total quantity of the nonionic emulsifier is in the range from 0.2 to 4.0%by weight, more preferably from 0.5 to 3.0%by weight and most preferably 1.3 to 2.8%by weight, calculated to the total weight of the emulsion.
For the case that at least one nonionic emulsifier selected from oleth-20, glyceryl stearate, glyceryl stearate SE and PEG-40 hydrogenated castor oil is contained, it is preferred if the total quantity of those nonionic emulsifier is in the range from 0.2 to 4.0%by weight, more preferably from 0.5 to 3.0%by weight and most preferably 1.3 to 2.8%by weight, calculated to the total weight of the emulsion.
According to the invention it is also preferred, if at least one anionic emulsifier is contained, which is advantageously selected from the group of anionic emulsifiers having a hlb value ranging from 8 to 18, in particular from 10 to 15.
Preferred anionic emulsifiers are selected from glyceryl stearate citrate, sodium cetearyl sulfate and glyceryl citrate.
According to the invention it is preferred if the total quantity of anionic emulsifier is in the range from 0.05 to 2.0%by weight, more preferably 0.07 to 0.3%by weight, calculated to the total weight of the emulsion.
According to the invention it is preferred if the total quantity of glyceryl stearate citrate, sodium cetearyl sulfate and/or glyceryl citrate is in the range from 0.05 to 2.0%by weight, more preferably 0.07 to 0.3%by weight, calculated to the total weight of the emulsion.
It is also advantageous according to the invention if further active ingredients are contained. These are advantageously selected from the group containing sodium hyaluronate, 1-methylhydantoin-2-imide, creatine, folic acid, panthenol, pantolactone, vitamin C, magnolia, calcium pantothenate and sodium ascorbyl phosphate. The active ingredients mentioned in the group are advantageously used in total proportions of up to 2%by weight, preferably less than 1%by weight, based on the total weight of the composition.
Further it is preferred if the emulsion is an oil in water emulsion.
Further it is preferred if water is contained in the emulsion in a total quantity ranging from 75.0%by weight to 95.0%by weight, calculated to the total weight of the emulsion.
Figures and its brief description
Figure 1 shows a picture of Example 1;
Figure 2 shows a picture of Example 2;
Figure 3 shows a picture of Example 3; and
Figure 4 shows a picture of Example 4.
Examples
The following examples should illustrate the compositions of this invention, without intending to limit the invention to these examples. The numerical values in the examples are percentages by weight, based on the total weight of the preparations.
The example Ex. 2 is according to the invention. The remaining examples are reference examples.
The anti-foaming properties of the formulas above were analyzed in the following manner:
1. prepare the material: test sample, Pipette which can measure 200μL sample, artificial skin (black PU artificial leather) , metronome, stopwatch, camera, photograph light box, and camera fixing system.
2. Apply 200μL of the example formulation on the left 1/3 of the artificial skin.
3. Start the metronome with 96 bpm, to make sure the spreading frequency is same in each testing.
4. Start the stopwatch to record the spread time, immediately start to spread the product on the artificial skin by moving 3 fingers right and left to the beat of the metronome for 30 sec.
5. Take a picture of the artificial skin. Then use image analyze software (imageJ) to adjust the picture to 8-digit gray mode.
6. The recorded pictures are presented in Figures 1 to 4, wherein the number of the picture corresponds to the number of the example formulation above.
Example 1 is a reference example containing methylheptylglycerin. Adding a hydrophobic particle, here silica cetyl silylate, allows a significant reduction of appearance of white foam, indicating a synergism (Ex. 2, Figure 2) . If only silica cetyl silylate is contained (Ex. 4) almost no reduction is observed (Figure 4) .
Further examples:
Ingrediens | Ex. 6 | Ex. 7 | Ex. 8 | Ex. 9 | Ex. 10 |
Methylheptylglycerin | 0.3 | 0.7 | 0.5 | 0.55 | 0.6 |
Dicaprylyl Ether | 1.9 | 0.5 | 1.2 | 1.6 | 1.0 |
Silica Cetyl Silylate (Aerosil R816) | 0.07 | 0.2 | 0.15 | 0.11 | 0.03 |
Ethylhexylglycerin | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
Caprylic/Capric Triglyceride | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 |
Butyrospermum Parkii Butter | 1.38 | 1.38 | 1.38 | 1.38 | 1.38 |
Sodium Cetearyl Sulfate | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 |
Glyceryl Stearate SE | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 |
Glycerin | 7 | 7 | 7 | 7 | 7 |
Phenoxyethanol | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 |
Cetearyl Alcohol | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 |
Gellan Gum | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
Xanthan Gum | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
Aqua | Ad 100 | Ad 100 | Ad 100 | Ad 100 | Ad 100 |
Ingrediens | Ex. 11 | Ex. 12 | Ex. 13 | Ex. 14 | Ex. 15 | Ex. 16 |
Methylheptylglycerin | 0.3 | 0.7 | 0.5 | 0.55 | 0.6 | 0.5 |
Silica caprylyl silylate | 0.01 | 0.07 | 0.03 | 0.02 | ||
Silica dimethyl silylate | 0.05 | 0.1 | 0.02 | 0.01 | ||
Disteayl Ether | 1.9 | 0.5 | 1.2 | 1.6 | 1.0 | |
Isopropyl Palmitate | 4.0 | |||||
Ethylhexylglycerin | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
Caprylic/Capric Triglyceride | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.0 |
Butyrospermum Parkii Butter | 1.38 | 1.38 | 1.38 | 1.38 | 1.38 | 1.2 |
Sodium Cetearyl Sulfate | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 |
Glyceryl Stearate SE | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 |
Glycerin | 7 | 7 | 7 | 7 | 7 | 6 |
Phenoxyethanol | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 |
Cetearyl Alcohol | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.1 |
Gellan Gum | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
Xanthan Gum | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
Aqua | Ad 100 | Ad 100 | Ad 100 | Ad 100 | Ad 100 | Ad 100 |
Claims (8)
- Cosmetic emulsion comprising based on the total weight of the compositiona. 0.05 to 5.0%by weight of methylheptylglycerin,b. At least one hydrophobic or hydrophobically modified particle,c. less than 0.1%or 0%by weight of a silicone oil.
- Emulsion according to claim 1 characterized in that the total quantity of methylheptylglycerin is in the range from 0.1 to 2%by weight, preferably from 0.2 to 1.5%by weight and more preferably from 0.3 to 1.1%by weight, calculated to the total weight of the emulsion.
- Emulsion according to one of the proceeding claims characterized in that the emulsion comprises at least a hydrophobically modified silica.
- Emulsion according to claim 3 characterized in that hydrophobically modified silica are selected from the group consisting of silica silylate, silica cetyl silylate, silica caprylyl silylate; silica dimethicone silylate and silica dimethyl silylate.
- Emulsion according to claim 3 or 4 characterized in that the total quantity of hydrophobically modified silica is in the range 0.01 to 2.0%by weight, preferably 0.02 to 1.0%by weight and more preferably 0.03 to 0.25%by weight calculated to the total weight of the emulsion.
- Emulsion according to claim 4 characterized in that the total quantity of silica silylate, silica cetyl silylate, silica caprylyl silylate; silica dimethicone silylate and/or silica dimethyl silylate is in the range 0.01 to 2.0%by weight, preferably 0.02 to 1.0%by weight and more preferably 0.03 to 0.25%by weight calculated to the total weight of the emulsion.
- Emulsion according to any proceeding claim characterized in that the hydrophobic or hydrophobically modified particles have a mean particle size of 17 to 300 μm, preferably 20 to 100 μm and more preferably 30 to 80 μm.
- Use of methylheptylglycerin in combination with at least one hydrophobic or hydrophobically modified particle, in particular a hydrophobically modified silica, for reducing white foam in a cosmetic emulsion.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2022/093730 WO2023221015A1 (en) | 2022-05-19 | 2022-05-19 | Cosmetic emulsion with reduced white appearance on skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2022/093730 WO2023221015A1 (en) | 2022-05-19 | 2022-05-19 | Cosmetic emulsion with reduced white appearance on skin |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023221015A1 true WO2023221015A1 (en) | 2023-11-23 |
Family
ID=88834227
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2022/093730 WO2023221015A1 (en) | 2022-05-19 | 2022-05-19 | Cosmetic emulsion with reduced white appearance on skin |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2023221015A1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003045340A1 (en) * | 2001-11-27 | 2003-06-05 | Unilever Plc | Hair treatment compositions |
CN103800212A (en) * | 2012-11-08 | 2014-05-21 | 花王株式会社 | Cleaner composition |
US20210322458A1 (en) * | 2020-04-20 | 2021-10-21 | Gregg Tobin | Methods and compositions for treatment of burns, joint pain, and fungal infections |
US20210363086A1 (en) * | 2020-05-22 | 2021-11-25 | Inolex Investment Corporation | Biobased alkyl glyceryl ethers and methods of making and using the same |
-
2022
- 2022-05-19 WO PCT/CN2022/093730 patent/WO2023221015A1/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003045340A1 (en) * | 2001-11-27 | 2003-06-05 | Unilever Plc | Hair treatment compositions |
CN103800212A (en) * | 2012-11-08 | 2014-05-21 | 花王株式会社 | Cleaner composition |
US20210322458A1 (en) * | 2020-04-20 | 2021-10-21 | Gregg Tobin | Methods and compositions for treatment of burns, joint pain, and fungal infections |
US20210363086A1 (en) * | 2020-05-22 | 2021-11-25 | Inolex Investment Corporation | Biobased alkyl glyceryl ethers and methods of making and using the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6935194B2 (en) | Cosmetic composition containing spicrysporic acid and at least one surfactant | |
US10342755B2 (en) | Cosmetic composition comprising specific combination of surfactants | |
DE102017223063A1 (en) | Hair treatment agent with anti-dandruff action | |
DE102014225606A1 (en) | Mild, nourishing anti-dandruff shampoo | |
US20200405591A1 (en) | Sprayable composition | |
KR102490687B1 (en) | Cleansing suitable composition | |
EP1704897B1 (en) | Foamable cosmetic compositions | |
FR3044922A1 (en) | ||
CN105163808A (en) | Hair care shampoo | |
FR3058639A1 (en) | CONDITIONER FOR HAIR CLEANING | |
FR3052052A1 (en) | ||
US11696886B2 (en) | Cosmetic | |
WO2023221015A1 (en) | Cosmetic emulsion with reduced white appearance on skin | |
WO2023221014A1 (en) | Cosmetic emulsion with reduced white foaming | |
US11285095B2 (en) | Hair oils for conditioning keratin fibres | |
KR101978827B1 (en) | Cosmetic composition of pump spray type with composing silicone composition for improving spray angle | |
WO2015086005A1 (en) | Cosmetic composition containing a combination of oligopeptides and ceramides | |
CN111712225B (en) | Oil-in-water type cosmetic composition with stable high content of oil | |
US20150118177A1 (en) | Method for producing a care cosmetic cleaning agent | |
US20190192397A1 (en) | Hair oils for conditioning keratin fibres | |
FR3053248A1 (en) | CLEANSING COMPOSITION FOR HAIR | |
WO2015086004A1 (en) | Cosmetic composition containing a combination of proteolipids and ceramides | |
US20200188287A1 (en) | Cosmetic agents for conditioning keratin fibres | |
FR3056905A1 (en) | COSMETIC COMPOSITION OF CLEANING PRODUCTS FOR LOW VISCOSITY FACE INTEGRATING MICELLAR TECHNOLOGY | |
US20050255064A1 (en) | Antiperspirant composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22942057 Country of ref document: EP Kind code of ref document: A1 |